272 related articles for article (PubMed ID: 19394062)
1. Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.
Yi F; Saha A; Murakami M; Kumar P; Knight JS; Cai Q; Choudhuri T; Robertson ES
Virology; 2009 Jun; 388(2):236-47. PubMed ID: 19394062
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
Saha A; Murakami M; Kumar P; Bajaj B; Sims K; Robertson ES
J Virol; 2009 May; 83(9):4652-69. PubMed ID: 19244339
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.
Cai Q; Guo Y; Xiao B; Banerjee S; Saha A; Lu J; Glisovic T; Robertson ES
PLoS Pathog; 2011 Dec; 7(12):e1002418. PubMed ID: 22174681
[TBL] [Abstract][Full Text] [Related]
4. EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.
Saha A; Bamidele A; Murakami M; Robertson ES
J Virol; 2011 Mar; 85(5):2079-88. PubMed ID: 21177815
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein.
Bajaj BG; Murakami M; Cai Q; Verma SC; Lan K; Robertson ES
J Virol; 2008 Apr; 82(8):4082-90. PubMed ID: 18256156
[TBL] [Abstract][Full Text] [Related]
6. E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.
Saha A; Lu J; Morizur L; Upadhyay SK; Aj MP; Robertson ES
PLoS Pathog; 2012; 8(3):e1002573. PubMed ID: 22438805
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor.
Sahu SK; Mohanty S; Kumar A; Kundu CN; Verma SC; Choudhuri T
Virology; 2014 Jan; 448():333-43. PubMed ID: 24314664
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
Saha A; Halder S; Upadhyay SK; Lu J; Kumar P; Murakami M; Cai Q; Robertson ES
PLoS Pathog; 2011 Feb; 7(2):e1001275. PubMed ID: 21347341
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7.
Parker GA; Crook T; Bain M; Sara EA; Farrell PJ; Allday MJ
Oncogene; 1996 Dec; 13(12):2541-9. PubMed ID: 9000128
[TBL] [Abstract][Full Text] [Related]
10. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
Banerjee S; Lu J; Cai Q; Saha A; Jha HC; Dzeng RK; Robertson ES
PLoS Pathog; 2013; 9(5):e1003314. PubMed ID: 23658517
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.
Jha HC; A J MP; Saha A; Banerjee S; Lu J; Robertson ES
J Virol; 2014 Apr; 88(7):3776-88. PubMed ID: 24429368
[TBL] [Abstract][Full Text] [Related]
12. An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.
Shukla SK; Jha HC; El-Naccache DW; Robertson ES
Oncotarget; 2016 Apr; 7(14):18116-34. PubMed ID: 26908453
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
[TBL] [Abstract][Full Text] [Related]
14. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
Zhang S; Pei Y; Lang F; Sun K; Singh RK; Lamplugh ZL; Saha A; Robertson ES
PLoS Pathog; 2019 Jan; 15(1):e1007514. PubMed ID: 30615685
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA.
Bain M; Watson RJ; Farrell PJ; Allday MJ
J Virol; 1996 Apr; 70(4):2481-9. PubMed ID: 8642676
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines.
Knight JS; Lan K; Subramanian C; Robertson ES
J Virol; 2003 Apr; 77(7):4261-72. PubMed ID: 12634383
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.
Knight JS; Sharma N; Robertson ES
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18562-6. PubMed ID: 16352731
[TBL] [Abstract][Full Text] [Related]
18. A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.
Knight JS; Sharma N; Kalman DE; Robertson ES
J Virol; 2004 Dec; 78(23):12857-67. PubMed ID: 15542638
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
[TBL] [Abstract][Full Text] [Related]
20. Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.
Gain C; Malik S; Bhattacharjee S; Ghosh A; Robertson ES; Das BB; Saha A
PLoS Pathog; 2020 Feb; 16(2):e1008105. PubMed ID: 32092124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
